Management of arterial hypertension

被引:27
作者
Wermelt, J. A. [1 ]
Schunkert, H. [1 ]
机构
[1] Tech Univ Munich, Klin Herz & Kreislauferkrankungen, Deutsch Herzzentrum Munchen, Lazarettstr 36, D-80636 Munich, Germany
关键词
Arterial hypertension; Diagnosis; Target blood pressure; Antihypertensive agents; Non-pharmacological treatment; SYSTOLIC BLOOD-PRESSURE; RISK-FACTORS; METAANALYSIS; MORTALITY; DISEASE; HOME;
D O I
10.1007/s00059-017-4574-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Arterial hypertension has a high prevalence and is a major risk factor for the development of cardiovascular diseases. It is a major contributor to worldwide morbidity and mortality and hence poses a huge socioeconomic burden. Despite great progress in perception, diagnosis and treatment of hypertension, blood pressure control is inadequate in less than half of the hypertensive patients (<140/90 mm Hg). The diagnosis of arterial hypertension starts in most patients with the conventional office blood pressure measurement. Out-of-office blood pressure measurement is an important adjunct, especially to unmask white-coat hypertension. To reach the right target blood pressure many effective antihypertensive drugs are available. By how much the blood pressure should be lowered is currently a matter of controversy. The 2013 European and the identical German national guidelines recommend a target blood pressure of <140/90 mm Hg for most patients. The recent SPRINT study revealed that some patients may benefit from an even lower blood pressure. This CME-article summarizes recent developments in the management of arterial hypertension and provides tips for daily practice based on these aims.
引用
收藏
页码:515 / 526
页数:12
相关论文
共 27 条
[1]   Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis [J].
Bliziotis, Ioannis A. ;
Destounis, Antonis ;
Stergiou, George S. .
JOURNAL OF HYPERTENSION, 2012, 30 (07) :1289-1299
[2]   Hypertension in 2017-What Is the Right Target? [J].
Chobanian, Aram V. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (06) :579-580
[3]  
DeutscheGesellschaft furKardiologie-Herz-und Kreislaufforschung e. V./Deutsche Hochdruckliga e. V, 2014, EUR HEART J, V34, P2159
[4]   Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis [J].
Ettehad, Dena ;
Emdin, Connor A. ;
Kiran, Amit ;
Anderson, Simon G. ;
Callender, Thomas ;
Emberson, Jonathan ;
Chalmers, John ;
Rodgers, Anthony ;
Rahimi, Kazem .
LANCET, 2016, 387 (10022) :957-967
[5]   Management of arterial hypertension [J].
Groha, P. ;
Schunkert, H. .
HERZ, 2015, 40 (06) :929-942
[6]  
Hausberg M, 2016, SPRINT STUDIE UPDATE
[7]  
James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427
[8]  
Jordan J, 2015, INTERNIST, V56, P219, DOI 10.1007/s00108-014-3572-0
[9]   Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany - Results from the MONICA Augsburg cohort study 1984-1992 [J].
Keil, U ;
Liese, AD ;
Hense, HW ;
Filipiak, B ;
Doring, A ;
Stieber, J ;
Lowel, H .
EUROPEAN HEART JOURNAL, 1998, 19 (08) :1197-1207
[10]  
Kintscher U, 2014, KARDIOLOGE, V8, P223, DOI 10.1007/s12181-014-0575-y